Patent · US Active

Methods and compositions for unsilencing imprinted genes

US9714427B2 · kind B2 · utility

2Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 9, 2011
Grant dateJul 25, 2017
Priority date
Expiry dateMay 8, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/713
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for inducing expression of Ube3a in a cell by contacting the cell with a topoisomerase inhibitor. Particular embodiments include a method of treating a genomic imprinting disorder, such as Angelman syndrome, in a subject by administering to the subject an effective amount of a topoisomerase inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.